These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Fukuyama congenital muscular dystrophy--history and perspectives].
    Author: Fukuyama Y.
    Journal: Brain Nerve; 2008 Jan; 60(1):43-51. PubMed ID: 18232332.
    Abstract:
    Congenital muscular dystrophy (CMD) is a newly established group of progressive muscular dystrophy, comprising a number of new entities, including Fukuyama congenital muscular dystrophy (FCMD). Victor Dubowitz (1997) wrote that to go back to the "dark ages", when there was still no CMD, we do not need to go back all that far; in the 1960s, many people were not recognizing the existence of CMD or in fact actively denying it. In 1960, Fukuyama and his colleagues published a short report of 15 CMD cases, delineating 9 clinical diagnostic criteria. In 1961, he presented detailed features of 25 cases at a formal national convention of Japanese Society of Neurology, the essence of which was widely approved by Japanese colleagues. The situation in foreign countries was quite different, however; its international recognition as a unique independent entity delayed till early 1980s. Eventually, FCMD was enlisted in MIM as OMIM 253800 in 1986, and in WHO's ICD-10 NA as G71.084 in 1990 for the first time. Toda et al localized a responsible FCMD gene at 9q31-33 in 1993 and identified fukutin gene in 1998. Another revolution took place in 1994, that is, laminin 2 deficiency was first identified in Western CMD patients by Tomé et al in 1994. This discovery gave a great impact to Western investigators, because in Western population, this condition is prevalent while FCMD was practically non-existent. World literature survey revealed that 1,963 articles on CMD had been published since 1893 till 2006, composing from 726 papers contributed by Japanese authors and 1,137 papers by non-Japanese authors. For the period 2001-2006, contribution by non-Japanese authors dramatically increased, occupying 66% of the total. Anyhow, the discovery of FCMD is worth as a historical landmark in dual sense. First, it convinced world authorities the fact the CMD is a real component of the muscular dystrophies family. Second, it provided a new concept on pathogenesis of muscular dystrophies in general, emphasizing multisystemic involvement rather than muscle alone.
    [Abstract] [Full Text] [Related] [New Search]